Crystal structure of the 20 S proteasome:TMC-95A complex: A non-covalent proteasome inhibitor

Journal of Molecular Biology

Volumn 311, Issue 3, 2001, Pages 543-548

  Groll, Michael ^a   Koguchi, Yutaka ^b   Huber, Robert ^a   Kohno, Jun ^b  

^a MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Drug design; Multicatalytic complex; Protease; Proteasome; Ubiquitin pathway

Indexed keywords

HETEROCYCLIC COMPOUND; NATURAL PRODUCT; PROTEASOME INHIBITOR;

AMINO TERMINAL SEQUENCE; ANTIGEN PRESENTATION; ARTICLE; CATALYSIS; CELL DIFFERENTIATION; COMPLEX FORMATION; COVALENT BOND; CRYSTAL STRUCTURE; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DENATURATION; SIGNAL TRANSDUCTION; X RAY CRYSTALLOGRAPHY;

EID: 0035902778     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.4869     Document Type: Article

References (36)

1. The proteasome
2. Structure and functions of the 20 S and 26 S proteasomes
3. The ubiquitin system
4. The 26 S proteasome: A molecular machine designed for controlled proteolysis
5. The base of the proteasome regulatory particle exhibits chaperone-like activity
6. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3
7. Structure of 20 S proteasome from yeast at 2.4 Å resolution
8. Crystal structure of the 20 S proteasome from the archaeon T. acidophilum at 3.4 Å resolution
9. Cleavage motifs of the yeast 20 S proteasome beta subunits deduced from digests of enolase 1
10. Biochemical properties of the proteasome from Thermoplasma acidophilum
11. Identification, purification, and characterization of a high molecular weight, ATP-dependent activator (PA700) of the 20 S proteasome
12. Activation of the multicatalytic protease. The 11 S regulator and 20 S ATPase complexes contain distinct 30-kilodalton subunits
13. A protein catalytic framework with an N-terminal nucleophile is capable of self-activation
14. Autocatalytic subunit processing couples active site formation in the 20 S proteasome to completion of assembly
15. Conformational constraints for protein self-cleavage in the proteasome
16. Analysis of mammalian 20 S proteasome biogenesis: The maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis
17. Autocatalytic processing of the 20 S proteasome
18. The catalytic sites of 20 S proteasomes and their role in subunit maturation: A mutational and crystallographic study
19. The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing
20. Peptide antigen production by the proteasome: Complexity provides efficiency
21. The proteasome system: A neglected tool for improvement of novel therapeutic strategies?
22. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities
23. Structures of TMC-95A-D: Novel proteasome inhibitors from Apiospora montagnei sacc. TC 1093
24. A gated channel into the proteasome core particle
25. Crystal structure of epoxomicin: 20 S proteasome reveals a molecular basis for selectivity of alpha', beta'-epoxyketone proteasome inhibitors
26. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes
27. Bivalency as a principle for proteasome inhibition
28. Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo anti-inflammatory activity
29. Inhibition of proteasome activities and subunit-specific aminoterminal threonine modification by lactacystin
30. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules
31. Bifunctional inhibitors of the trypsin-like activity of eukaryotic proteasomes
32. A graphic model building and refinement system for macromolecules
33. Accurate bond and angles parameters for X-ray protein structure refinement